查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球支氣管擴張劑市場規模研究與預測：按適應症（哮喘、慢性阻塞性肺病、其他）、藥物類型、給藥途徑、區域分析，2022-2029 年
市場調查報告書
商品編碼
1261218

全球支氣管擴張劑市場規模研究與預測：按適應症（哮喘、慢性阻塞性肺病、其他）、藥物類型、給藥途徑、區域分析，2022-2029 年

Global Bronchodilators Market Size study & Forecast, by Indication (Asthma, Chronic obstructive pulmonary disease, Others), by Drug Type, by Route Of Administration and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球支氣管擴張劑市場價值約為 337.8 億美元，預計在 2022-2029 年預測期內將以超過 5.2% 的健康增長率增長。我在這裡。

支氣管擴張劑是一種藥物，可以放鬆肺部氣道（支氣管）中的肌肉並擴張它們，使呼吸更順暢。 它可以改善肺部的氣流並降低氣道阻力。 此外，支氣管擴張劑用於減少肺部粘液。 這些藥物由呼吸系統疾病患者使用吸入器或霧化器服用。 吸入支氣管擴張劑也會影響粘液清除。 通過放鬆肺部肌肉和擴大氣道，支氣管擴張劑可用於治療阻塞性肺病（支氣管）。 肺部疾病治療意識的提高、老年人口的增加和吸煙者數量的增加是推動全球市場需求的主要因素。

肺部疾病患病率上升是全球市場增長的主要推動力。 例如，世界衛生組織（WHO）將呼吸道疾病引起的傳染病列為第三大死亡原因，每年約有 300 萬人死亡（佔全球所有死亡人數的 6%），而慢性阻塞性肺病約 90% 的死亡發生在低收入和中等收入國家 70 歲以上的人。 據估計，全世界有 2.62 億人患有哮喘，其中大多數是年輕人。 因此，各種呼吸系統和肺部疾病的高發，大大增加了市場需求。 此外，全球污染水平上升和與支氣管擴張劑相關的研發投資增加在預測期內提供了各種有利可圖的機會。 然而，支氣管擴張劑的副作用、審批週期長和嚴格的法規阻礙了整個 2022-2029 年預測期內的市場增長。

全球支氣管擴張劑市場研究考慮的主要區域是亞太地區、北美、歐洲、中美洲和南美洲以及世界其他地區。 由於人們對治療慢性阻塞性肺病、哮喘和其他慢性呼吸道疾病的認識不斷提高和政府舉措不斷增加，北美在收入方面佔據了市場主導地位。 另一方面，由於呼吸道疾病患者人數增加、醫療基礎設施改善以及製藥行業對支氣管擴張劑的需求增加等因素，預計亞太地區在預測期內將以最高複合年增長率增長。

本研究的目的是闡明近年來各個細分市場和國家/地區的市場規模，並預測未來幾年的市場規模。 該報告旨在捕捉被調查國家行業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還包含供利益相關者投資的潛在微觀市場機會，以及對主要參與者的競爭格局和產品供應的深入分析。 .

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年各細分市場的全球市場估計和預測
    • 2019-2029 年各地區支氣管擴張劑市場
    • 支氣管擴張劑市場，按適應症，2019-2029
    • 支氣管擴張劑市場，按藥物類型，2019-2029 年
    • 支氣管擴張劑市場，按給藥途徑，2019-2029
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章全球支氣管擴張劑市場定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 本次調查涵蓋的年份
  • 貨幣兌換率

第3章支氣管擴張劑的全球市場動態

  • 支氣管擴張劑市場影響分析（2019-2029）
    • 市場驅動因素
      • 吸煙人數增加
      • 肺病患病率上升
    • 市場挑戰
      • 支氣管擴張劑的副作用
      • 審批週期長，監管嚴格
    • 市場機會
      • 全球污染加劇
      • 擴大對支氣管擴張劑相關研發的投資

第 4 章全球支氣管擴張器市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 主要投資機會
  • 關鍵成功策略
  • 業內人士的前景
  • 分析師的建議和結論

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球支氣管擴張劑市場：按適應症分類

  • 市場概況
  • 全球支氣管擴張劑市場：按適應症、性能潛力分析
  • 2019-2029 年全球支氣管擴張劑市場、按適應症估計和預測
  • 支氣管擴張劑市場細分分析
    • 支氣管哮喘
    • 慢性阻塞性肺疾病 (COPD)
    • 其他

第 7 章全球支氣管擴張劑市場：按藥物類型分類

  • 市場概況
  • 全球支氣管擴張劑市場：按藥物類型、性能潛力分析
  • 2019-2029 年按藥物類型分列的全球支氣管擴張劑市場估計和預測
  • 支氣管擴張劑市場細分分析
    • 擬交感神經藥
    • 抗膽鹼藥
    • 磷酸二酯□抑製劑
    • 聯合代理

第 8 章全球支氣管擴張劑市場：按給藥途徑

  • 市場概況
  • 全球支氣管擴張劑市場：按給藥途徑），性能潛力分析
  • 2019-2029 年全球支氣管擴張劑市場、按給藥途徑估計和預測
  • 支氣管擴張劑市場細分分析
    • 口語
    • 注射
    • 吸入器

第 9 章全球支氣管擴張劑市場：區域分析

  • 支氣管擴張劑市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 2019-2029 年各適應症的估計和預測
      • 2019-2029 年按藥物類型估算和預測
      • 按給藥途徑估算和預測，2019-2029 年
    • 加拿大
  • 歐洲支氣管擴張劑市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區支氣管擴張劑市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲支氣管擴張劑市場概況
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 世界其他地方

第 10 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • 雅培實驗室
      • 關鍵信息
      • 概覽
      • 財務（僅當數據可用時）
      • 產品概述
      • 近期趨勢
    • AstraZeneca plc.
    • Boehringer Ingelheim International GmbH
    • GlaxoSmithKline Plc.
    • F. Hoffmann-La Roche Ltd.
    • Novartis AG.
    • Pfizer Inc.
    • SANOFI
    • Teva Pharmaceutical Industries Ltd.
    • Vectura Group Plc

第 11 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查的特點
  • 調查先決條件

Global Bronchodilators Market is valued at approximately USD 33.78 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2022-2029. A bronchodilator is a type of drug that relaxes the muscles in the lungs (bronchi) airway passageways and widens them to make breathing easier. They enhance airflow within the lungs and lessen resistance in the respiratory tract. Additionally, bronchodilators are utilized to lessen pulmonary mucus. These medications are taken by patients with respiratory conditions using inhalers or nebulizers. Inhalation bronchodilators additionally influence mucociliary clearance. By relaxing the muscles in the lungs and enlarging the airways, bronchodilators are employed in the treatment of obstructive lung disorders (bronchi). The growing awareness regarding the treatment of lung diseases, increasing geriatric population, coupled with the rise in number of smokers are the primary factors that are fostering the market demand across the globe.

The rising prevalence of lung diseases is acting as a chief driving factor for the growth of the global market. For instance, the World Health Organization (WHO) lists respiratory disease infections as the third leading cause of mortality, accounting for around 3 million deaths per year (or 6% of all fatalities worldwide), with nearly 90% of COPD fatalities occurring in individuals over 70 from low- and middle-income nations. Also, it is estimated that 262 million people worldwide have asthma, which typically affects youngsters. Thus, the high incidences of various respiratory and lung diseases are augmenting the market demand at a substantial rate. Moreover, the heightened pollution levels globally, as well as the growing R&D investments related to bronchodilators are presenting various lucrative opportunities over the forecasting years. However, the adverse effects of bronchodilators and long approval times and stringent regulations are hindering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Bronchodilators Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing awareness regarding the treatment of COPD, asthma, and other chronic respiratory disorders, along with the rising number of government initiatives. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as the high presence of respiratory disorder patient pool, improving healthcare infrastructure, and rise in demand for bronchodilators in the pharmaceutical sector across the regional market.

Major market players included in this report are:

  • Abbott Laboratories
  • AstraZeneca plc.
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline Plc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG.
  • Pfizer Inc.
  • SANOFI
  • Teva Pharmaceutical Industries Ltd.
  • Vectura Group Plc

Recent Developments in the Market:

  • In May 2020, Glenmark Pharmaceuticals Ltd. declared that the company has successfully launched its Single Inhaler Triple Therapy (AIRZ-FF) which is a combination of two bronchodilators, namely, Formoterol and Glycopyrronium, and corticosteroid Fluticasone propionate. The product is specially designed for Chronic Obstructive Pulmonary Disease (COPD) patients in India.
  • In October 2020, Zydus Cadila announced that the company received final approval from the United States Food and Drug Administration (USFDA) to trade its Albuterol Tablets (in the strengths of 2 mg and 4 mg) which are used to treat and prevent bronchospasm.

Global Bronchodilators Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Indication, Drug Type, Route Of Administration, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Indication:

  • Asthma
  • Chronic obstructive pulmonary disease (COPD)
  • Others

By Drug Type:

  • Sympathomimetics
  • Anticholinergics
  • Phosphodiesterase Inhibitor
  • Combination Drugs

By Route Of Administration:

  • Oral
  • Injection
  • Inhaler

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Bronchodilators Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Bronchodilators Market, by Indication, 2019-2029 (USD Billion)
    • 1.2.3. Bronchodilators Market, by Drug Type, 2019-2029 (USD Billion)
    • 1.2.4. Bronchodilators Market, by Route Of Administration, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Bronchodilators Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Bronchodilators Market Dynamics

  • 3.1. Bronchodilators Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase in number of smokers
      • 3.1.1.2. Rising prevalence of lung diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. Adverse effects of bronchodilators
      • 3.1.2.2. Long approval times and stringent regulations
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Heightened pollution levels globally
      • 3.1.3.2. Growing R&D investments related to bronchodilators

Chapter 4. Global Bronchodilators Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Bronchodilators Market, by Indication

  • 6.1. Market Snapshot
  • 6.2. Global Bronchodilators Market by Indication, Performance - Potential Analysis
  • 6.3. Global Bronchodilators Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
  • 6.4. Bronchodilators Market, Sub Segment Analysis
    • 6.4.1. Asthma
    • 6.4.2. Chronic obstructive pulmonary disease (COPD)
    • 6.4.3. Others

Chapter 7. Global Bronchodilators Market, by Drug Type

  • 7.1. Market Snapshot
  • 7.2. Global Bronchodilators Market by Drug Type, Performance - Potential Analysis
  • 7.3. Global Bronchodilators Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
  • 7.4. Bronchodilators Market, Sub Segment Analysis
    • 7.4.1. Sympathomimetics
    • 7.4.2. Anticholinergics
    • 7.4.3. Phosphodiesterase Inhibitor
    • 7.4.4. Combination Drugs

Chapter 8. Global Bronchodilators Market, by Route Of Administration

  • 8.1. Market Snapshot
  • 8.2. Global Bronchodilators Market by Route Of Administration, Performance - Potential Analysis
  • 8.3. Global Bronchodilators Market Estimates & Forecasts by Route Of Administration 2019-2029 (USD Billion)
  • 8.4. Bronchodilators Market, Sub Segment Analysis
    • 8.4.1. Oral
    • 8.4.2. Injection
    • 8.4.3. Inhaler

Chapter 9. Global Bronchodilators Market, Regional Analysis

  • 9.1. Bronchodilators Market, Regional Market Snapshot
  • 9.2. North America Bronchodilators Market
    • 9.2.1. U.S. Bronchodilators Market
      • 9.2.1.1. Indication breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Drug Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Route Of Administration breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Bronchodilators Market
  • 9.3. Europe Bronchodilators Market Snapshot
    • 9.3.1. U.K. Bronchodilators Market
    • 9.3.2. Germany Bronchodilators Market
    • 9.3.3. France Bronchodilators Market
    • 9.3.4. Spain Bronchodilators Market
    • 9.3.5. Italy Bronchodilators Market
    • 9.3.6. Rest of Europe Bronchodilators Market
  • 9.4. Asia-Pacific Bronchodilators Market Snapshot
    • 9.4.1. China Bronchodilators Market
    • 9.4.2. India Bronchodilators Market
    • 9.4.3. Japan Bronchodilators Market
    • 9.4.4. Australia Bronchodilators Market
    • 9.4.5. South Korea Bronchodilators Market
    • 9.4.6. Rest of Asia Pacific Bronchodilators Market
  • 9.5. Latin America Bronchodilators Market Snapshot
    • 9.5.1. Brazil Bronchodilators Market
    • 9.5.2. Mexico Bronchodilators Market
    • 9.5.3. Rest of Latin America Bronchodilators Market
  • 9.6. Rest of The World Bronchodilators Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Abbott Laboratories
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. AstraZeneca plc.
    • 10.2.3. Boehringer Ingelheim International GmbH
    • 10.2.4. GlaxoSmithKline Plc.
    • 10.2.5. F. Hoffmann-La Roche Ltd.
    • 10.2.6. Novartis AG.
    • 10.2.7. Pfizer Inc.
    • 10.2.8. SANOFI
    • 10.2.9. Teva Pharmaceutical Industries Ltd.
    • 10.2.10. Vectura Group Plc

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Bronchodilators Market, report scope
  • TABLE 2. Global Bronchodilators Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Bronchodilators Market estimates & forecasts by Indication 2019-2029 (USD Billion)
  • TABLE 4. Global Bronchodilators Market estimates & forecasts by Drug Type 2019-2029 (USD Billion)
  • TABLE 5. Global Bronchodilators Market estimates & forecasts by Route Of Administration 2019-2029 (USD Billion)
  • TABLE 6. Global Bronchodilators Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Bronchodilators Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Bronchodilators Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Bronchodilators Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Bronchodilators Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Bronchodilators Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Bronchodilators Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Bronchodilators Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Bronchodilators Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Bronchodilators Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Bronchodilators Market
  • TABLE 71. List of primary sources, used in the study of global Bronchodilators Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Bronchodilators Market, research methodology
  • FIG 2. Global Bronchodilators Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Bronchodilators Market, key trends 2021
  • FIG 5. Global Bronchodilators Market, growth prospects 2022-2029
  • FIG 6. Global Bronchodilators Market, porters 5 force model
  • FIG 7. Global Bronchodilators Market, pest analysis
  • FIG 8. Global Bronchodilators Market, value chain analysis
  • FIG 9. Global Bronchodilators Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Bronchodilators Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Bronchodilators Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Bronchodilators Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Bronchodilators Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Bronchodilators Market, regional snapshot 2019 & 2029
  • FIG 15. North America Bronchodilators Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Bronchodilators Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Bronchodilators Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Bronchodilators Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Bronchodilators Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable